A recent breakthrough in high intensity focused ultrasound therapy technology has proven its effectiveness in treating cancer.
HIFU therapy is a non-invasive targeted treatment that uses sound waves to eradicate cancer cells. It uses an ultrasonic transducer to convert electrical signals into sound waves, then concentrates the ultrasound in a small focal region to raise the temperature to over 65 degrees Celsius, thereby killing the cancer cells in the process without damaging the surrounding tissues.
Sound waves prove to be a reliable treatment against cancer:
High intensity focused ultrasound therapy has been shown to be a very effective anti-cancer therapy in various studies and clinical trials.
For example, researchers at University College Hospital in London examined 625 men with prostate cancer and found that 93% of patients who had undergone HIFU treatment remained without cancer five years after treatment without having undergone any treatment. surgery or radiotherapy.
The data also showed that only 1-2% of patients who had HIFU treatment had long-term urinary incontinence, compared to 10-20% of patients who had surgery.
In addition, only 15 percent of patients in the HIFU group developed erectile dysfunction versus 30 to 60 percent of patients in surgery.
As Tim Dudderidge, co-author of the study, explains, "The results of this study are impressive and have the potential to transform the treatment of prostate cancer for many men in the future."
"This is an extremely exciting technology and these results show that in early-diagnosed men, this targeted therapy could be as effective as surgery to remove the entire prostate gland, or radiotherapy by causing far fewer side effects." .